Moreover, ANXA4 was found to be upregulated in human primary HCC tissues, promotes HCC cell proliferation, and ANXA4 knockdown decreased the tumorigenic potential in a subcutaneous xenograft model and that ANXA4 is crucial for HCC proliferation (Liu et al., 2017). Here, ANXA4 is linked to hepatocellular carcinoma.